Table 2.
Prevalence of Lifetime Mental Health Disorders and Substance Use Disorders Among Sexual Minority Men and Women: NESARC Wave 2 (2004–2005)
| Sexual minority men | Sexual minority women | |||||
|---|---|---|---|---|---|---|
| Never experienced discrimination (n = 127) | Ever experienced discrimination (n = 144) | Never experienced discrimination (n = 181) | Ever experienced discrimination (n = 125) | |||
| % (95% CI) | % (95% CI) | P | % (95% CI) | % (95% CI) | P | |
| Lifetime mental health disorders | ||||||
| Any mood disorder | 0.12 | 0.11 | ||||
| Yes | 33.4 (22.6–46.2) | 46.3 (36.2–56.7) | 47.5 (39.4–55.7) | 58.7 (47.5–69.1) | ||
| No | 66.6 (53.8–77.4) | 53.7 (43.4–63.8) | 52.5 (4.3–60.6) | 41.3 (31.0–52.6) | ||
| Major depressive episode | 0.22 | 0.02 | ||||
| Yes | 31.6 (21.5–43.8) | 41.4 (31.3–52.3) | 40.6 (32.8–49.0) | 56.9 (45.6–67.5) | ||
| No | 68.4 (56.2–78.5) | 58.6 (47.7–68.7) | 59.4 (51.0–67.2) | 43.1 (32.5–54.4) | ||
| Manic episode | 0.61 | 0.43 | ||||
| Yes | 8.4 (3.7–17.9) | 10.6 (6.2–17.6) | 9.2 (5.7–14.6) | 12.2 (7.0–20.6) | ||
| No | 91.6 (82.1–96.3) | 89.4 (82.4–93.8) | 90.8 (85.4–94.3) | 87.8 (79.4–93.0) | ||
| Dysthymic episode | 0.29 | 0.11 | ||||
| Yes | 7.2 (3.3–15.1) | 11.7 (7.3–18.2) | 10.8 (6.3–17.8) | 19.1 (11.8–29.3) | ||
| No | 92.8 (85.0–96.7) | 88.3 (81.8–92.7) | 89.2 (82.2–93.7) | 80.9 (70.7–88.2) | ||
| Hypomanic episode | 0.05 | 0.35 | ||||
| Yes | 1.7 (0.6–5.1) | 6.2 (2.5–14.8) | 10.0 (5.74–17.1) | 5.3 (1.4–18.5) | ||
| No | 98.3 (94.9–99.4) | 93.8 (85.2–97.5) | 90.0 (82.9–94.3) | 94.7 (81.5–98.6) | ||
| Any anxiety disorder | 0.87 | <0.01 | ||||
| Yes | 39.8 (29.6–50.9) | 41.0 (30.6–52.3) | 41.0 (33.0–49.5) | 62.4 (51.5–72.7) | ||
| No | 60.2 (49.1–70.4) | 59.0 (47.7–69.4) | 59.0 (50.5–67.0) | 37.6 (27.8–48.5) | ||
| Panic disorder without agoraphobia | <0.001 | 0.02 | ||||
| Yes | 15.4 (8.7–25.8) | 13.3 (8.0–21.3) | 12.3 (7.2–20.3) | 26.0 (16.5–38.5) | ||
| No | 84.6 (74.2–91.3) | 86.7 (78.7–92.0) | 87.7 (79.7–92.8) | 74.0 (61.5–83.6) | ||
| Panic disorder with agoraphobia | <0.001 | 0.07 | ||||
| Yes | 0.2 (<0.01–1.7) | 5.1 (2.2–11.4) | 3.8 (1.5–9.1) | 10.8 (4.9–22.1) | ||
| No | 99.8 (98.3–100.0) | 94.9 (88.6–97.8) | 96.2 (90.9–98.5) | 89.2 (77.9–95.1) | ||
| Agoraphobia without history of panic disorder | 0.34 | 0.40 | ||||
| Yes | 1.0 (0.2–4.4) | 2.4 (0.6–8.8) | 0.5 (<0.01–3.4) | 1.4 (0.2–9.6) | ||
| No | 99.0 (95.6–99.8) | 97.6 (91.2–99.4) | 99.6 (96.6–99.9) | 98.6 (90.4–99.8) | ||
| Social phobia | 0.12 | 0.25 | ||||
| Yes | 8.5 (4.2–16.7) | 16.2 (9.7–25.6) | 12.2 (8.1–18.0) | 17.2 (10.6–26.7) | ||
| No | 91.5 (83.3–95.8) | 83.8 (74.4–90.3) | 87.8 (82.0–91.9) | 82.8 (73.3–89.4) | ||
| Specific phobia | 0.80 | 0.02 | ||||
| Yes | 20.5 (13.4–30.0) | 21.8 (15.7–29.5) | 25.2 (18.9–32.7) | 40.4 (30.0–51.7) | ||
| No | 79.5 (70.0–86.6) | 78.2 (70.5–84.3) | 74.8 (67.3–81.1) | 59.7 (48.4–70.0) | ||
| Posttraumatic stress disorder | 0.12 | 0.88 | ||||
| Yes | 7.8 (3.5–16.7) | 15.7 (10.3–23.3) | 22.3 (15.6–30.8) | 23.7 (15.3–34.9) | ||
| No | 92.2 (83.3–96.5) | 84.3 (76.7–89.7) | 77.7 (69.2–84.4) | 76.3 (65.2–84.7) | ||
| Generalized anxiety disorder | 0.66 | 0.02 | ||||
| Yes | 14.0 (7.6–24.5) | 16.4 (10.5–24.7) | 13.5 (8.6–20.6) | 26.5 (17.7–37.7) | ||
| No | 86.0 (75.5–92.4) | 83.6 (75.3–89.5) | 86.5 (79.4–91.4) | 73.5 (62.3–82.3) | ||
| Lifetime substance use disorders | ||||||
| Alcohol use disorder | 0.20 | 0.90 | ||||
| Yes | 51.6 (40.9–62.1) | 60.7 (50.3–70.2) | 56.1 (47.4–64.5) | 55.3 (44.1–66.1) | ||
| No | 48.4 (38.0–59.1) | 39.3 (29.8–49.7) | 43.9 (35.5–52.6) | 44.7 (33.9–55.9) | ||
| Nicotine dependence | 0.89 | 0.34 | ||||
| Yes | 33.5 (24.3–44.2) | 32.6 (23.7–42.9) | 35.3 (27.0–44.5) | 42.3 (31.8–53.5) | ||
| No | 66.5 (55.9–75.7) | 67.4 (57.1–76.3) | 64.7 (55.5–73.0) | 57.7 (46.5–68.2) | ||
| Any drug use disordera | <0.001 | 0.98 | ||||
| Yes | 15.5 (9.6–24.0) | 41.9 (32.1–52.4) | 33.2 (25.2–42.3) | 33.4 (23.3–45.2) | ||
| No | 84.6 (76.0–90.5) | 58.1 (47.6–67.9) | 66.8 (57.7–74.8) | 66.6 (54.8–76.7) | ||
| Any prescription drug use disorderb | 0.14 | 0.88 | ||||
| Yes | 8.6 (4.1–17.3) | 16.2 (9.9–25.4) | 13.0 (7.6–21.4) | 12.2 (5.9–23.5) | ||
| No | 91.4 (82.7–96.0) | 83.8 (74.6–90.1) | 87.0 (78.6–92.4) | 87.8 (76.5–94.1) | ||
| Cannabis use disorder | <0.001 | 0.95 | ||||
| Yes | 10.7 (5.8–18.7) | 35.1 (25.1–46.5) | 25.3 (18.2–34.1) | 25.7 (17.1–36.7) | ||
| No | 89.3 (81.3–94.2) | 64.9 (53.5–74.9) | 74.7 (65.9–81.8) | 74.3 (63.3–82.9) | ||
| Other drug use disorderc | 0.01 | 0.38 | ||||
| Yes | 5.2 (1.9–13.6) | 19.1 (12.0–28.9) | 13.5 (8.5–20.9) | 18.4 (9.9–31.6) | ||
| No | 94.8 (86.4–98.1) | 80.9 (71.1–88.0) | 86.5 (79.1–91.5) | 81.6 (68.4–90.1) | ||
a
Any drug use disorder includes sedatives, tranquilizers, opioids, amphetamine, cannabis, hallucinogen, cocaine, inhalants/solvents, heroin, and other drug use disorder.
b
Any prescription drug use disorder includes sedatives, tranquilizers, opioids, and amphetamine use disorder.
c
Other drug use disorder includes hallucinogen, cocaine, inhalants/solvents, heroin, and other drug use disorder.
%, weighted.